XML 48 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option and SARs activities and related information for the year ended December 31, 2016, is as follows:

 

     Number of
options and
SAR units
     Weighted
average
exercise
price
     Weighted
average
remaining
contractual
term
     Aggregate
intrinsic-
value
 

Outstanding at the beginning of the year

     2,406,455      $ 18.15        

Granted (1)

     104,000        28.42        

Exercised

     (1,012,151      16.89        

Forfeited or expired

     (42,396      17.93        
  

 

 

    

 

 

       

Outstanding at the end of the year (2)

     1,455,908      $ 19.76        4.7      $ 20,077  
  

 

 

    

 

 

    

 

 

    

 

 

 

Vested or expected to vest at the end of the year

     1,422,492      $ 19.78        4.7      $ 19,587  
  

 

 

    

 

 

    

 

 

    

 

 

 

Exercisable at the end of the year (3)

     972,229      $ 19.88        3.9      $ 13,286  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

  (1) In 2016, the Company granted 104,000 stock options only to non-employee directors of the Company. No SARs were granted during 2016.
  (2) Due to the ceiling imposed on the SAR grants, the outstanding amount equals a maximum of 1,305,719 shares of the Company’s common stock issuable upon exercise.
  (3) Due to the ceiling imposed on the SAR grants, the exercisable amount equals a maximum of 882,273 shares of the Company’s common stock issuable upon exercise.
Schedule of Options Granted, Classified into Range of Exercise Price

The options and SARs granted to employees of the Company and its subsidiaries and the options granted to non-employee directors of the Company which were outstanding as of December 31, 2016 have been classified into a range of exercise prices as follows:

 

     Outstanding      Exercisable  

Exercise price

(range)

  
Number

of
options
     Weighted
average
remaining
contractual
life (years)
     Weighted
average
exercise
price
    
Number
of
options
     Weighted
average
remaining
contractual
life (years)
     Weighted
average
exercise
price
 

12.60-15.54

     396,969        4.7      $ 14.63        237,614        4.1      $ 14.59  

16.08-18.62

     381,257        4.1      $ 16.72        292,617        4.1      $ 16.73  

19.36-24.86

     438,579        4.4      $ 21.65        306,895        3.4      $ 22.26  

27.01-32.34

     239,103        6.4      $ 29.67        135,103        3.9      $ 30.62  
  

 

 

          

 

 

       
     1,455,908        4.7      $ 19.76        972,229        3.9      $ 19.88  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
Summary of Restricted Stock Units Activity

A summary of the Company’s RSU activities and related information for the year ended December 31, 2016, is as follows:

 

     Number of
RSUs
     Weighted average
Grant-Date
fair value
 

Unvested as at the beginning of the year

     234,000      $ 19.89  

Granted

     394,417        22.05  

Vested

     (99,972      19.73  

Forfeited

     (23,303      20.16  
  

 

 

    

Unvested at the end of the year

     505,142      $ 21.59  
  

 

 

    

 

 

 

Expected to vest at the end of the year

     463,757      $ 21.58